课题基金 / 基金详情

Depressive and bipolar disorders: Pathophysiology, phenotypes and treatment innovations

Depressive and bipolar disorders: Pathophysiology, phenotypes and treatment innovations
抑郁症和双相情感障碍:病理生理学、表型和治疗创新
批准号:
nhmrc : 1037196
负责人:
Prof Gordon Parker
金额:
$498.05万
依托单位国家:
澳大利亚
项目类别:
Program Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2018-12-31

项目摘要

项目成果

Prof Gordon Parker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Depression and bipolar disorder are two of Australia’s leading causes of disease burden, with 3-4 million Australians affected during their lifetime. However, despite being such a serious health burden, there are major shortcomings to current understanding and management. This research program aims to further our knowledge of the causes and presentations of the mood disorders, and to improve and “tailor” treatment for the many Australians who suffer from these highly disabling illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Depressive and bipolar disorders: Causes, presentation and treatment innovations
  • 批准号:
    nhmrc : GNT1037196
  • 项目类别:
    Programs
  • 资助金额:
    $710.06万
  • 财政年份:
    2013
  • 负责人:
    Prof Gordon Parker
  • 依托单位:
Typology, aetiology and neurobiology of the depressive and bipolar disorders
  • 批准号:
    nhmrc : 993208
  • 项目类别:
    Programs
  • 资助金额:
    $171.47万
  • 财政年份:
    1999
  • 负责人:
    Prof Gordon Parker
  • 依托单位:
国内基金
海外基金
双极性躁郁症(Bipolar Disorder)的人诱导多能干细胞模型的建立和神经病理研究
  • 批准号:
    31471020
  • 项目类别:
    面上项目
  • 资助金额:
    87.0万元
  • 批准年份:
    2014
  • 负责人:
    姚骏
  • 依托单位: